14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRMD
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

CorMedix Inc stock price ended at $5.45 on Tuesday, after gaining 3.22%.
(Updated on Apr 23, 2024)

Buy or Hold candidate since Mar 13, 2024 Gain 39.74% PDF

The CorMedix Inc stock price gained 3.22% on the last trading day (Tuesday, 23rd Apr 2024), rising from $5.28 to $5.45. During the last trading day the stock fluctuated 6.06% from a day low at $5.26 to a day high of $5.58. The price has risen in 5 of the last 10 days and is up by 14.74% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 110 thousand more shares were traded than the day before. In total, 573 thousand shares were bought and sold for approximately $3.12 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 61.58% during the next 3 months and, with a 90% probability hold a price between $7.46 and $10.86 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRMD Signals & Forecast

The CorMedix Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.38 and $4.44. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, April 11, 2024, and so far it has fallen -14.71%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for CorMedix Inc stock

CorMedix Inc finds support from accumulated volume at $5.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.319 between high and low, or 6.06%. For the last week, the stock has had daily average volatility of 9.25%.

Our recommended stop-loss: $5.14 (-5.64%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (CRMD) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect CorMedix Inc to open at $5.43, and during the day (based on 14 day Average True Range), to move between $5.01 and $5.89, which gives a possible trading interval of +/-$0.435 (+/-7.99%) up or down from last closing price. If CorMedix Inc takes out the full calculated possible swing range there will be an estimated 15.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.38 (1.28%) than the resistance at $5.84 (7.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CorMedix Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for CorMedix Inc stock to perform well in the short-term.

Current score: 3.271 Buy Candidate Unchanged

Predicted Opening Price for CorMedix Inc of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$5.43 ( 0.374%) $5.45

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRMD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.75 5.48 %
R2 5.63 3.24 %
R1 5.55 1.86 %
Current price: 5.45
Support S1 5.31 -2.61 %
S2 5.23 -3.99 %
S3 5.11 -6.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 6.39 17.25 %
R1 5.84 7.16 %
Current price 5.45
Support S1 5.38 -1.28%
S2 5.28 -3.12%
S3 4.18 -23.30%

FAQ

What is the symbol for CorMedix Inc Stock and on which exchange is it traded?
The symbol for CorMedix Inc is CRMD and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell CorMedix Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for CorMedix Inc stock to perform well in the short-term.

How to buy CorMedix Inc Stock?
CorMedix Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CorMedix Inc Stock.

What's the current price of CorMedix Inc Stock?
As of the end of day on the Apr 23, 2024, the price of an CorMedix Inc (CRMD) share was $5.45.

What is the 52-week high and low for CorMedix Inc Stock?
The 52-week high for CorMedix Inc Stock is $6.89 and the 52-week low is $2.57.

What is the market capitalization of CorMedix Inc Stock?
As of the Apr 23, 2024, the market capitalization of CorMedix Inc is 289.407M.

When is the next earnings date for CorMedix Inc?
The upcoming earnings date for CorMedix Inc is May 13, 2024.
Click to get the best stock tips daily for free!

About CorMedix Inc

CorMedix CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical setting... CRMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT